肝脑病:关于病理生理学和管理的当前想法
Barun Kumar Sen1, Kausik Pan1, Ambar Chakravarty2
1Department of Neurology, Vivekananda Institute of Medical Sciences, Kolkata, West Bengal, India.
Current neurology and neuroscience reports
|March 28, 2025
概括
肝发性脑病 (HE) 涉及由于肝功能不充分而导致的神经和精神问题,通常是由氨积累引起的. 治疗重点是减少氨和管理肠道毒素,肝移植是最后的手段.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 神经学 神经学
- 胃肠病学 胃肠病学
背景情况:
- 肝发性脑病 (HE) 是肝功能障碍的一个复杂的神经精神疾病并发症.
- 它呈现为从微妙的认知变化到昏迷的频谱.
- 病理生理学包括高血,神经炎症和肠-大脑轴障碍.
研究的目的:
- 审查肝脏脑病变的原因,类型和临床阶段.
- 讨论目前对HE病原遗传机制的理解.
- 概述目前在高等教育中实践的治疗方案.
主要方法:
- 对HE的原因,机制和治疗方法的文献综述.
- 对目前关于氨代谢和神经炎症的研究进行分析.
- 讨论治疗策略,包括药理和支持措施.
主要成果:
- 他包括隐蔽和公开的形式,隐蔽的他显示行为和认知障碍.
- 超血症,神经炎症 (TNF-α,IL-6,IL-17),肠道失调,以及金属沉积 (,) 都会导致HE.
- 治疗包括乳糖,利法西明,L-ornithine L-aspartate (LOLA),在耐火病例中,肝移植或肝辅助设备.
结论:
- HE的发病是多因素的,涉及氨毒性,神经炎症和肠道衍生毒素.
- 治疗方法旨在减少氨的产生/吸收,并减轻神经炎症.
- 管理策略正在不断发展,如肝移植等先进的选择提供了最终的治疗方法.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
884
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Encephalitis l: Introduction
15
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Encephalitis ll: Pathophysiology
22
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Cerebral Edema ll: Pathophysiology
19
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53


